stars 1 stars 2 stars 3

Founded in 2005, ORTHOCON is a startup therapeutic device company that develops, manufactures, markets and sells innovative surgical products that stop the bleeding from and deliver drugs to bone. In 2010, ORTHOCON launched its first FDA-cleared product, the HEMASORB Absorbable Bone Hemostat Matrix. ORTHOCON believes its products have the potential to provide significant benefits to millions of patients each year.

ORTHOCON Questions

The ORTHOCON annual revenue was $8 million in 2026.

Richard Kronenthal is the Founder, VP, CSO of ORTHOCON.

2 people are employed at ORTHOCON.

ORTHOCON is based in Irvington, New York.

The NAICS codes for ORTHOCON are [3254, 32541, 325, 32].

The SIC codes for ORTHOCON are [38, 384].

Top ORTHOCON Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users